Scherle Peggy

Insider CIK 1824632 · PRLD Chief Scientific Officer

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
PRLD Prelude Therapeutics Inc	A Award deriv	2026-02-04	2026-02-05	230,000	—	$0	230,000	SEC↗
PRLD Prelude Therapeutics Inc	A Award deriv	2025-02-04	2025-02-05	175,000	—	$0	175,000	SEC↗
PRLD Prelude Therapeutics Inc	A Award deriv	2024-03-01	2024-03-04	150,000	—	$0	150,000	SEC↗
PRLD Prelude Therapeutics Inc	A Award deriv	2023-02-07	2023-02-09	135,000	—	$0	135,000	SEC↗
PRLD Prelude Therapeutics Inc	A Award deriv	2022-02-15	2022-02-17	100,000	—	$0	100,000	SEC↗
PRLD Prelude Therapeutics Inc	M Exercise deriv	2021-08-27	2021-08-30	6,014	—	$0	27,018	SEC↗
PRLD Prelude Therapeutics Inc	S Sale	2021-08-27	2021-08-30	2,707	$36.23	$98.1K	173,527	SEC↗
PRLD Prelude Therapeutics Inc	S Sale	2021-08-27	2021-08-30	2,700	$35.32	$95.4K	176,234	SEC↗
PRLD Prelude Therapeutics Inc	M Exercise	2021-08-27	2021-08-30	6,014	$1.43	$8.6K	178,934	SEC↗
PRLD Prelude Therapeutics Inc	S Sale	2021-08-27	2021-08-30	607	$37.08	$22.5K	172,920	SEC↗
PRLD Prelude Therapeutics Inc	M Exercise deriv	2021-08-26	2021-08-30	1,700	—	$0	33,032	SEC↗
PRLD Prelude Therapeutics Inc	M Exercise	2021-08-26	2021-08-30	1,700	$1.43	$2.4K	174,620	SEC↗
PRLD Prelude Therapeutics Inc	S Sale	2021-08-26	2021-08-30	1,700	$35.19	$59.8K	172,920	SEC↗
PRLD Prelude Therapeutics Inc	M Exercise deriv	2021-08-13	2021-08-17	1,728	—	$0	34,732	SEC↗
PRLD Prelude Therapeutics Inc	M Exercise deriv	2021-08-13	2021-08-17	558	—	$0	42,672	SEC↗
PRLD Prelude Therapeutics Inc	S Sale	2021-08-13	2021-08-17	2,286	$35.07	$80.2K	172,920	SEC↗
PRLD Prelude Therapeutics Inc	M Exercise	2021-08-13	2021-08-17	558	$1.89	$1.1K	173,478	SEC↗
PRLD Prelude Therapeutics Inc	M Exercise	2021-08-13	2021-08-17	1,728	$1.43	$2.5K	175,206	SEC↗
PRLD Prelude Therapeutics Inc	M Exercise deriv	2021-07-27	2021-07-29	20,000	—	$0	36,460	SEC↗
PRLD Prelude Therapeutics Inc	M Exercise	2021-07-27	2021-07-29	20,000	$1.43	$28.6K	192,920	SEC↗
PRLD Prelude Therapeutics Inc	S Sale	2021-07-27	2021-07-29	680	$36.09	$24.5K	172,920	SEC↗
PRLD Prelude Therapeutics Inc	S Sale	2021-07-27	2021-07-29	19,320	$35.45	$684.9K	173,600	SEC↗
PRLD Prelude Therapeutics Inc	A Award deriv	2021-07-20	2021-07-22	95,000	—	$0	95,000	SEC↗
PRLD Prelude Therapeutics Inc	M Exercise deriv	2021-05-07	2021-05-11	10,000	—	$0	56,460	SEC↗
PRLD Prelude Therapeutics Inc	S Sale	2021-05-07	2021-05-11	3,964	$40.30	$159.7K	178,956	SEC↗
PRLD Prelude Therapeutics Inc	S Sale	2021-05-07	2021-05-11	5,836	$41.14	$240.1K	173,120	SEC↗
PRLD Prelude Therapeutics Inc	S Sale	2021-05-07	2021-05-11	200	$41.85	$8.4K	172,920	SEC↗
PRLD Prelude Therapeutics Inc	M Exercise	2021-05-07	2021-05-11	10,000	$1.43	$14.3K	182,920	SEC↗
PRLD Prelude Therapeutics Inc	M Exercise deriv	2021-04-08	2021-04-15	4,630	—	$0	66,460	SEC↗
PRLD Prelude Therapeutics Inc	S Sale	2021-04-08	2021-04-15	669	$38.97	$26.1K	174,589	SEC↗
PRLD Prelude Therapeutics Inc	S Sale	2021-04-08	2021-04-15	875	$37.72	$33.0K	175,258	SEC↗
PRLD Prelude Therapeutics Inc	S Sale	2021-04-08	2021-04-15	1,417	$36.97	$52.4K	176,133	SEC↗
PRLD Prelude Therapeutics Inc	S Sale	2021-04-08	2021-04-15	1,669	$39.57	$66.0K	172,920	SEC↗
PRLD Prelude Therapeutics Inc	A Award	2021-04-08	2021-04-15	4,630	$1.43	$6.6K	177,550	SEC↗
PRLD Prelude Therapeutics Inc	M Exercise deriv	2021-04-07	2021-04-09	15,370	—	$0	71,090	SEC↗
PRLD Prelude Therapeutics Inc	A Award	2021-04-07	2021-04-09	15,370	$1.43	$22.0K	188,290	SEC↗
PRLD Prelude Therapeutics Inc	S Sale	2021-04-07	2021-04-09	6,881	$39.63	$272.7K	173,120	SEC↗
PRLD Prelude Therapeutics Inc	S Sale	2021-04-07	2021-04-09	8,289	$39.02	$323.4K	180,001	SEC↗
PRLD Prelude Therapeutics Inc	S Sale	2021-04-07	2021-04-09	200	$40.30	$8.1K	172,920	SEC↗